Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines

• Үндсэн зохиолчид: Md. Jamal Hossain (Зохиогч), Ali A. Rabaan (Зохиогч), Abbas Al Mutair (Зохиогч), Saad Alhumaid (Зохиогч), Talha Bin Emran (Зохиогч), G Saikumar (Зохиогч), Saikat Mitra (Зохиогч), Kuldeep Dhama (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Taylor & Francis Group, 2022-01-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have recently been reported in many countries. These have exacerbated the coronavirus disease 2019 (COVID-19)-induced global health threats and hindered COVID-19 vaccine development and therapeutic progress. This commentar...